Klein et al., 1990 - Google Patents
Demonstration of “naturally occurring mitochondrial antibodies” in family members of patients with primary biliary cirrhosisKlein et al., 1990
View PDF- Document ID
- 3128675800394896971
- Author
- Klein R
- Berg P
- Publication year
- Publication venue
- Hepatology
External Links
Snippet
Sera from 81 healthy family members (including husbands) of 13 patients with primary biliary cirrhosis were tested by Western blotting against the antigen fractions M9 and M2 derived respectively from rat liver and beef heart mitochondria. Fifty–eight (70%) were …
- 206010004661 Biliary cirrhosis primary 0 title abstract description 87
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Araujo et al. | Antigenemia in recently acquired acute toxoplasmosis | |
| Kovacs et al. | Identification of antigens and antibodies specific for Pneumocystis carinii. | |
| Izui et al. | Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. | |
| Veldkamp et al. | Application of the enzyme-linked immunosorbent assay (ELISA) in the serodiagnosis of syphilis. | |
| FRφLAND et al. | Immunological characterization of lymphocytes in synovial fluid from patients with rheumatoid arthritis | |
| US20240216507A1 (en) | Sars-cov-2-specific t cells and methods of treatment using them | |
| CA2121030A1 (en) | Type c-like human retrovirus linked to multiple sclerosis (ms) | |
| Berg et al. | Heterogeneity of antimitochondrial antibodies | |
| Klein et al. | Sera from patients with tuberculosis recognize the M2a‐epitope (E2‐subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis | |
| Klein et al. | Demonstration of “naturally occurring mitochondrial antibodies” in family members of patients with primary biliary cirrhosis | |
| Berg et al. | Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9 | |
| JPH08511865A (en) | Parvovirus receptor and method of use | |
| Aiuti et al. | Surface markers on lymphocytes of patients with infectious diseases | |
| EP0260691A2 (en) | Immunotherapy for aids patients | |
| JP3550410B2 (en) | Monoclonal antibodies that bind to basophils, methods for separating basophils, methods for releasing chemical mediators from basophils, and methods for releasing basophil-derived chemical mediators | |
| Aiuti et al. | Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies | |
| Pedersen et al. | Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody against the Reiter treponeme flagellum in syphilis | |
| Bartfeld et al. | Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens | |
| CA1240937A (en) | Monoclonal igm antibodies and method of preparation | |
| Klein et al. | Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space | |
| HUSBY et al. | Smooth muscle antibody in heroin addicts | |
| Chen | Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to Angiostrongylus cantonensis | |
| Wells et al. | Antibodies to human collagen in subjects with selective IgA deficiency | |
| Gilhus et al. | Myasthenia gravis: Difference between thymoma‐associated antibodies and crossstriational skeleta1 muscle antibodies | |
| JPH0239746B2 (en) |